Cargando…
BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells
PURPOSE: BOL-303242-X is a novel selective glucocorticoid receptor agonist under clinical evaluation for the treatment of inflammatory skin and eye diseases. Data from in vitro and in vivo studies suggest an improved side-effect profile of this compound compared to classical glucocorticoids. The aim...
Autores principales: | Zhang, Jin-Zhong, Cavet, Megan E., VanDerMeid, Karl R., Salvador-Silva, Mercedes, López, Francisco J., Ward, Keith W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790480/ https://www.ncbi.nlm.nih.gov/pubmed/20011631 |
Ejemplares similares
-
Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy
por: Baiula, Monica, et al.
Publicado: (2014) -
Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells
por: Cavet, Megan E., et al.
Publicado: (2010) -
A method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using Luminex
por: VanDerMeid, Karl R., et al.
Publicado: (2011) -
On the structure of Bol algebras
por: Bouetou, T B
Publicado: (2001) -
Acute phase responses induced in dwarf goats by r.BolL(−1β), r.BolL(−2) and r.BolFN(−γ)
por: Duin, C. T. M. van, et al.
Publicado: (1992)